Sangamo selects winning bids in Chapter 11 asset auction for USD 163.55 million cash at close

Reuters2026/08/12 20:28

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Sangamo Therapeutics selected winning bids in a court-supervised Chapter 11 asset auction totaling USD 163.55 million cash at closing.
PTC Therapeutics set to buy the Fabry disease program ST-920 for USD 111 million, with up to USD 100 million tied to FDA approvals.
Eli Lilly to acquire capsid delivery, zinc finger, MINT platforms, and prion program ST-506 for USD 50 million in cash.
Separate sales of tools and equipment expected to add USD 2.55 million in cash proceeds at closing.
Transactions await U.S. Bankruptcy Court sign-off; Lilly closing targeted around Sept. 4, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sangamo Therapeutics Inc. published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经•2026/09/14 00:46

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260

Reuters•2026/09/14 00:39

Oman postpones the meeting originally scheduled for the 14th with Iran and other countries; the US warns: Don't expect a breakthrough in the Strait of Hormuz

华尔街见闻•2026/09/14 00:23